Pages that link to "Q44590209"
Jump to navigation
Jump to search
The following pages link to Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs (Q44590209):
Displaying 50 items.
- Overutilization of proton-pump inhibitors: what the clinician needs to know (Q24634086) (← links)
- Acid suppression and the risk of Clostridium difficile infection (Q26823599) (← links)
- Management of the patient with incomplete response to PPI therapy (Q27025882) (← links)
- Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis (Q30431802) (← links)
- Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications (Q33949498) (← links)
- Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis (Q34026230) (← links)
- Revision of failed transoral incisionless fundoplication by subsequent laparoscopic Nissen fundoplication (Q34647624) (← links)
- Proton pump inhibitor step-down therapy for GERD: A multi-center study in Japan (Q34756783) (← links)
- Treatment of gastroesophageal reflux disease (Q35752712) (← links)
- Review article: diagnosis and management of night-time reflux (Q35939808) (← links)
- Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease? (Q35987877) (← links)
- Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next? (Q36191254) (← links)
- Treatment of uncomplicated reflux disease (Q36204260) (← links)
- Review article: alternative approaches to the long-term management of GERD. (Q36319540) (← links)
- Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management (Q36554323) (← links)
- Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure (Q36895523) (← links)
- Proton pump inhibitor prescriptions and subsequent use in US veterans diagnosed with gastroesophageal reflux disease (Q36927372) (← links)
- Capsule commentary on Gawron et al., proton pump inhibitor prescriptions and subsequent use in US veterans diagnosed with gastroesophageal reflux disease (Q36927385) (← links)
- Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors. (Q37018462) (← links)
- EndoCinch treatment for gastro-oesophageal reflux disease (Q37050869) (← links)
- Diet and lifestyle modifications in the management of gastroesophageal reflux disease (Q37205411) (← links)
- Step-up and step-down approaches to treatment of gastroesophageal reflux disease in children (Q37215537) (← links)
- Ensocopic-endoluminal therapies. A critical appraisal (Q37815300) (← links)
- The relationship among proton pump inhibitors, bone disease and fracture (Q37877712) (← links)
- Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk? (Q38011261) (← links)
- Current pharmacological management of gastroesophageal reflux disease. (Q38123482) (← links)
- The role of bile acids in functional GI disorders. (Q38217671) (← links)
- PPI-Refractory GERD: an Intriguing, Probably Overestimated, Phenomenon (Q38539973) (← links)
- Deprescribing versus continuation of chronic proton pump inhibitor use in adults. (Q38903118) (← links)
- Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial (Q39308874) (← links)
- Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review. (Q41405986) (← links)
- Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms (Q41435411) (← links)
- Issues Related to BID Dosing of PPIs (Q42035997) (← links)
- The herbal medicine rikkunshito exhibits strong and differential adsorption properties for bile salts (Q42112666) (← links)
- Patients with refractory gastroesophageal reflux disease: diagnostic tools (Q42406559) (← links)
- The Role of Weakly Acidic Reflux in Proton Pump Inhibitor Failure, Has Dust Settled? (Q42656069) (← links)
- Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse (Q42955085) (← links)
- Editorial: just how "difficult" is it to withdraw PPI treatment? (Q42981048) (← links)
- Therapy for gastroesophageal reflux disease: more is not necessarily better (Q44590205) (← links)
- An old tool may fix a new problem: early utilization of 24-h esophageal pH monitoring may reduce unnecessary proton-pump inhibitor use and improve outcomes (Q45267152) (← links)
- Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease. (Q46037784) (← links)
- Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database (Q47984107) (← links)
- Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey (Q48629907) (← links)
- The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital (Q49988267) (← links)
- Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution (Q50046112) (← links)
- Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease (Q50129556) (← links)
- 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study (Q50963449) (← links)
- Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease (Q51142763) (← links)
- Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX. (Q51650418) (← links)
- Review of Proton Pump Inhibitor Overuse in the US Veteran Population. (Q55230586) (← links)